Overview

Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients with Major Depressive Disorder

Status:
RECRUITING
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
This study aimed to evaluate the efficacy and safety of fecal microbiota transplantation (FMT) in patients with major depressive disorder (MDD) who exhibit suboptimal early response to antidepressant treatment. Additionally, it sought to investigate the impact of FMT on biological indicators, including intestinal microbiota and metabolites, in individuals with MDD
Phase:
NA
Details
Lead Sponsor:
Gang Wang
Collaborators:
Shandong Daizhuang Hospital
The First Affiliated Hospital, Zhejiang University
The First Hospital of Hebei Medical University
Tianjin Anding Hospital
West China Hospital
Wuhu Fourth People's Hospital
Treatments:
Escitalopram
Fecal Microbiota Transplantation
Microbiota
Starch